FAK in cancer: mechanistic findings and clinical applications
FJ Sulzmaier, C Jean, DD Schlaepfer - Nature reviews cancer, 2014 - nature.com
Focal adhesion kinase (FAK) is a cytoplasmic protein tyrosine kinase that is overexpressed
and activated in several advanced-stage solid cancers. FAK promotes tumour progression …
and activated in several advanced-stage solid cancers. FAK promotes tumour progression …
[HTML][HTML] MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
M Felder, A Kapur, J Gonzalez-Bosquet, S Horibata… - Molecular cancer, 2014 - Springer
Over three decades have passed since the first report on the expression of CA125 by
ovarian tumors. Since that time our understanding of ovarian cancer biology has changed …
ovarian tumors. Since that time our understanding of ovarian cancer biology has changed …
[HTML][HTML] Integrated genomic characterization of papillary thyroid carcinoma
Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer. Here, we
describe the genomic landscape of 496 PTCs. We observed a low frequency of somatic …
describe the genomic landscape of 496 PTCs. We observed a low frequency of somatic …
[HTML][HTML] Organoid cultures derived from patients with advanced prostate cancer
The lack of in vitro prostate cancer models that recapitulate the diversity of human prostate
cancer has hampered progress in understanding disease pathogenesis and therapy …
cancer has hampered progress in understanding disease pathogenesis and therapy …
[HTML][HTML] Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin
KA Hoadley, C Yau, DM Wolf, AD Cherniack… - Cell, 2014 - cell.com
Recent genomic analyses of pathologically defined tumor types identify" within-a-tissue"
disease subtypes. However, the extent to which genomic signatures are shared across …
disease subtypes. However, the extent to which genomic signatures are shared across …
Proteogenomic characterization of human colon and rectal cancer
Extensive genomic characterization of human cancers presents the problem of inference
from genomic abnormalities to cancer phenotypes. To address this problem, we analysed …
from genomic abnormalities to cancer phenotypes. To address this problem, we analysed …
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in …
Background Maintenance monotherapy with the PARP inhibitor olaparib significantly
prolonged progression-free survival (PFS) versus placebo in patients with platinum-sensitive …
prolonged progression-free survival (PFS) versus placebo in patients with platinum-sensitive …
[HTML][HTML] The landscape of kinase fusions in cancer
N Stransky, E Cerami, S Schalm, JL Kim… - Nature …, 2014 - nature.com
Human cancer genomes harbour a variety of alterations leading to the deregulation of key
pathways in tumour cells. The genomic characterization of tumours has uncovered …
pathways in tumour cells. The genomic characterization of tumours has uncovered …
Genetic landscape of esophageal squamous cell carcinoma
Esophageal squamous cell carcinoma (ESCC) is one of the deadliest cancers. We
performed exome sequencing on 113 tumor-normal pairs, yielding a mean of 82 non-silent …
performed exome sequencing on 113 tumor-normal pairs, yielding a mean of 82 non-silent …
[HTML][HTML] Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy
JG Lohr, P Stojanov, SL Carter, P Cruz-Gordillo… - Cancer cell, 2014 - cell.com
We performed massively parallel sequencing of paired tumor/normal samples from 203
multiple myeloma (MM) patients and identified significantly mutated genes and copy number …
multiple myeloma (MM) patients and identified significantly mutated genes and copy number …